Cure My Disease

Don't miss your cure!

 Log in / Sign up

Gene study aims to personalize breast cancer hormone treatment

NCT ID NCT01127295

Completed Knowledge-focused Sponsor: Institut Claudius Regaud Source: ClinicalTrials.gov ↗

First seen May 03, 2026 · Last updated May 12, 2026 · Updated 4 times

Summary

This study enrolled 2000 women with hormone-sensitive breast cancer who were already scheduled to receive hormone therapy after surgery. Researchers measured drug levels in the blood and analyzed genetic differences to see how these factors relate to side effects and early cancer return. The goal is to learn how to tailor hormone therapy for each patient.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HORMONO-DEPENDING ADJUVANT BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • CHU de Bordeaux

    Bordeaux, 33000, France

  • CHU de Rangueil

    Toulouse, 31059, France

  • Centre Catalan d'Oncologie

    Perpignan, 66000, France

  • Centre Hospitalier Intercommunal de Castres-Mazamet

    Castres, 81108, France

  • Centre Hospitalier d'Auch

    Auch, 32008, France

  • Centre Hospitalier de Brive

    Brive-la-Gaillarde, 19312, France

  • Centre Hospitalier de Cahors

    Cahors, 46005, France

  • Centre Hospitalier de Mont de Marsan

    Mont-de-Marsan, 40024, France

  • Centre Hospitalier de Montauban

    Montauban, 82013, France

  • Centre Hospitalier de Pau

    Pau, 64000, France

  • Centre Hospitalier de Rodez

    Rodez, 12000, France

  • Centre Val d'Aurelle

    Montpellier, 34298, France

  • Claudius Regaud

    Toulouse, 31052, France

  • Clinique Calabet

    Agen, 47000, France

  • Clinique Claude Bernard

    Albi, 81030, France

  • Clinique Pasteur - Département d'Oncologie Médicale

    Toulouse, 31076, France

  • Clinique Pasteur - Département de Radiothérapie

    Toulouse, 31300, France

  • Clinique Saint-Jean du Languedoc

    Toulouse, 31400, France

  • Clinique Tivoli

    Bordeaux, 33000, France

  • Hôpital Caremeau CHU Nîmes

    Nîmes, 30029, France

  • Hôpital Dupuytren CHU Limoges

    Limoges, 87042, France

  • Institut Bergonié

    Bordeaux, 33076, France

  • Polyclinique Bordeaux Nord

    Bordeaux, 33077, France

  • Polyclinique de l'Ormeau

    Tarbes, 65000, France

Conditions

Explore the condition pages connected to this study.

HORMONO-DEPENDING ADJUVANT BREAST CANCER